Immune cells track hard-to-target brain tumours

Neeha Zaidi; Elizabeth M. Jaffee

doi:10.1038/d41586-018-07728-9

Immune cells track hard-to-target brain tumours

Neeha Zaidi, Elizabeth M. Jaffee

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

9 Scopus citations

Abstract

Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don’t usually respond to immunotherapy. The findings also point to how to improve such treatments.

Original language	English (US)
Pages (from-to)	170-171
Number of pages	2
Journal	Nature
Volume	565
Issue number	7738
DOIs	https://doi.org/10.1038/d41586-018-07728-9
State	Published - Jan 10 2019

Keywords

Cancer
Immunology

ASJC Scopus subject areas

General

Access to Document

10.1038/d41586-018-07728-9

Cite this

@article{cccb1a417f824b43a14a2eed6809fcba,

title = "Immune cells track hard-to-target brain tumours",

abstract = "Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don{\textquoteright}t usually respond to immunotherapy. The findings also point to how to improve such treatments.",

keywords = "Cancer, Immunology",

author = "Neeha Zaidi and Jaffee, {Elizabeth M.}",

note = "Publisher Copyright: {\textcopyright} 2019, Nature.",

year = "2019",

month = jan,

day = "10",

doi = "10.1038/d41586-018-07728-9",

language = "English (US)",

volume = "565",

pages = "170--171",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Publishing Group",

number = "7738",

}

TY - JOUR

T1 - Immune cells track hard-to-target brain tumours

AU - Zaidi, Neeha

AU - Jaffee, Elizabeth M.

PY - 2019/1/10

Y1 - 2019/1/10

N2 - Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don’t usually respond to immunotherapy. The findings also point to how to improve such treatments.

AB - Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don’t usually respond to immunotherapy. The findings also point to how to improve such treatments.

KW - Cancer

KW - Immunology

UR - http://www.scopus.com/inward/record.url?scp=85059734067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059734067&partnerID=8YFLogxK

U2 - 10.1038/d41586-018-07728-9

DO - 10.1038/d41586-018-07728-9

M3 - Comment/debate

C2 - 30622348

AN - SCOPUS:85059734067

SN - 0028-0836

VL - 565

SP - 170

EP - 171

JO - Nature

JF - Nature

IS - 7738

ER -

Immune cells track hard-to-target brain tumours

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this